Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test in UAE | 1,500 AED | DHA Licensed Facility

Executive Summary & Core Metrics

Diagnostic Accuracy: 99.9% analytical sensitivity for selected markers via ISO 9001:2015 certified real-time PCR processing.
Specimen Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Clinical Consultation: Post-test telephonic interpretation with a Consultant Medical Genetics specialist.
Insurance & Billing: Direct verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test is a targeted molecular diagnostic assay that detects six predefined genetic mutations directly implicated in leukemogenesis. Using real-time PCR (qPCR) technology on DNA extracted from blood or bone marrow, the test delivers definitive qualitative evidence of specific genomic alterations. This enables haematologists and oncologists to confirm leukaemia subtype classification, stratify prognostic risk, and select rationally targeted therapeutic regimens with high precision.

Methodology Comparison: Targeted qPCR vs. Broad NGS

Feature	Our Test – PCR Qualitative	Standard NGS Panel
Method	Real-Time PCR (qPCR) – targeted, high-sensitivity	Next‑Generation Sequencing – broad genome scan
Turnaround Time	2–3 business days	7–10 business days
Price (AED)	1,500	3,000+
Analytical Sensitivity	>99 % for selected markers	95–98 %
Processing Schedule	Fixed (Tue/Fri by 11 am; reports Thu/Mon)	Variable

* Comparison based on published laboratory performance data. NGS may offer broader genomic coverage but typically at higher cost and longer turnaround.

Physician Insight & Safety Protocols

"As a Consultant Medical Genetics specialist, I consider this targeted genetic profile an essential tool for confirming leukaemia subtype and identifying actionable mutations. The qualitative PCR readout provides rapid, unambiguous evidence that directly informs risk stratification and therapy selection. Nonetheless, results must be integrated with full clinical, morphological, and immunophenotypic data for comprehensive patient management."

— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

Important Advisory

Do not discontinue any prescribed medication without prior consultation with your treating physician.

Safety & Exclusion Criteria

Patients unable to provide informed consent or those with active uncontrolled bleeding disorders.
Active infection at the planned venipuncture or bone marrow aspiration site.
Severe coagulopathy (INR >1.5) or platelet count <50,000/µL without haematology clearance.
Emergency red flags: sudden fever >38 °C, persistent bleeding, severe pain, or swelling after sample collection – seek immediate medical attention.

Patient FAQ & Clinical Guidance

1. What is the Leukemia Genetic Profile PCR Qualitative Test?

This is a targeted molecular diagnostic assay that qualitatively identifies six key genetic mutations associated with leukaemia. It employs real-time PCR technology on DNA extracted from blood or bone marrow to deliver definitive mutation detection, guiding diagnosis, subtype classification, risk stratification, and targeted therapy selection. Results are reported as detected or not detected for each marker.

2. How should I prepare for this test?

Inform your referring physician about all current medications and provide a brief clinical history. No fasting is required for the blood draw. If a bone marrow aspiration is clinically indicated, a local anaesthetic will be administered; follow all pre‑procedure instructions provided by your haematologist. Arrange for a companion to drive you home if sedation is used during the marrow procedure.

3. How long does it take to receive results?

Results are typically available within 2–3 business days after sample receipt. Specimens are processed on Tuesdays and Fridays before 11:00 am, with reports released on Thursdays and Mondays respectively. You will receive a confidential digital copy along with a telephonic consultation from our clinical team to interpret the findings in the context of your overall health status.

4. Will my insurance cover the cost of this test?

Coverage varies by insurance provider and policy. Our billing team can verify your eligibility and provide a pre‑authorisation estimate. Contact us via WhatsApp at +971 54 548 8731 for direct insurance verification and any out‑of‑pocket cost details.

UAE Regulatory & Data Privacy Adherence

All laboratory services are delivered under ISO 9001:2015 Quality Management (Cert: INT/EGQ/2509DA/3139). Patient data is encrypted and processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Specimen collection is performed by DHA-licensed professionals; for minors, written parental or guardian consent is mandatory.

Clinical & Logistical Metadata

Test Name	Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test
Price (AED)	1,500
Turnaround Time	2–3 business days (fixed schedule: Tue/Fri processing, Thu/Mon reporting)
Sample Type / Matrix	Blood (peripheral whole blood) or Bone Marrow — Hospital Extraction Only; mobile home phlebotomy is disabled for safety.
Methodology Used	Real‑Time PCR (qPCR) – Qualitative Detection
ICD-10-CM Code	C95.9 (Leukemia, unspecified), Z01.818 (Encounter for other specified special examinations)
LOINC Code	98531-5 (Leukemia related gene mutations panel DNA)
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE